Coverage
-
July 21, 2016
A Delaware federal judge on Wednesday told Dr. Reddy's Laboratories Inc. that it can't move AstraZeneca's trademark infringement suit over Dr. Reddy's purple generic of the heartburn drug Nexium to New Jersey, and dismissed counterclaims that the lawsuit breached an earlier settlement agreement.
3 other articles on this case.
View all »